title: Identifying biomarkers: where is the scientific methodology? Comment on the article by Sanayama et Al.
authors.affiliation: New York University Hospital for Joint Diseases, New York, NY.
authors.forename: Yusuf
authors.initials: Y
authors.lastname: Yazici
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000097:blood*; D007963:Leukocytes, Mononuclear / Q000378:metabolism*; D008297:Male; D008668:Metallothionein / Q000097:blood*; D020411:Oligonucleotide Array Sequence Analysis
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007370:Interferon Type I; D008668:Metallothionein